Abstract
Treatment landscape for advanced cervical cancer (aCC) is evolving with immunotherapy in addition to chemotherapy demonstrating overall survival benefit in the KEYNOTE-826. This study aims to provide a baseline view of real-world aCC care patterns in England, 2012-2019, to inform future potential benefit as more therapies become available for this patient population.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
